Last reviewed · How we verify
Furosemide and matched saline hydration — Competitive Intelligence Brief
phase 3
Loop diuretic with intravenous fluid replacement
Na-K-2Cl cotransporter (NKCC2) in the loop of Henle
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Furosemide and matched saline hydration (Furosemide and matched saline hydration) — Centro Cardiologico Monzino. Furosemide is a loop diuretic that inhibits sodium and chloride reabsorption in the ascending limb of the loop of Henle, promoting fluid excretion, while saline hydration provides intravenous fluid replacement to maintain hemodynamic stability.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Furosemide and matched saline hydration TARGET | Furosemide and matched saline hydration | Centro Cardiologico Monzino | phase 3 | Loop diuretic with intravenous fluid replacement | Na-K-2Cl cotransporter (NKCC2) in the loop of Henle |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Loop diuretic with intravenous fluid replacement class)
- Centro Cardiologico Monzino · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Furosemide and matched saline hydration CI watch — RSS
- Furosemide and matched saline hydration CI watch — Atom
- Furosemide and matched saline hydration CI watch — JSON
- Furosemide and matched saline hydration alone — RSS
- Whole Loop diuretic with intravenous fluid replacement class — RSS
Cite this brief
Drug Landscape (2026). Furosemide and matched saline hydration — Competitive Intelligence Brief. https://druglandscape.com/ci/furosemide-and-matched-saline-hydration. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab